{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:08:26Z","timestamp":1791403706894,"version":"4.3.3"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["fsijournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.forsciint.2014.08.002","type":"journal-article","created":{"date-parts":[[2014,8,17]],"date-time":"2014-08-17T12:16:12Z","timestamp":1408277772000},"page":"149-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["A mixed MDPV and benzodiazepine intoxication in a chronic drug abuser: Determination of MDPV metabolites by LC\u2013HRMS and discussion of the case"],"prefix":"10.1016","volume":"243","author":[{"given":"Elisabetta","family":"Bertol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Boscolo Berto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Mannaioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Vaiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donata","family":"Favretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2014.08.002_bib0005","first-page":"624","article-title":"Emergency department visits after use of a drug sold as bath salts","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0010","series-title":"US Department of Justice Drug Enforcement Administration, Background, data and analysis of synthetic cathinones: mephredrone (4-MMC), methylone (MDMC) and 3,4-methylenedioxyprovalerone (MDPV)","year":"2012"},{"key":"10.1016\/j.forsciint.2014.08.002_bib0015","series-title":"US Drug Enforcement Administration, Methylenedioxyprovalerone","year":"2010"},{"key":"10.1016\/j.forsciint.2014.08.002_bib0020","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/15563650.2011.590812","article-title":"Clinical experience with and analytical confirmation of bath salts and legal highs (synthetic cathinones) in the United States","volume":"49","author":"Spiller","year":"2011","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.forsciint.2014.08.002_bib0025","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.amjmed.2012.02.019","article-title":"Psychoactive bath salts intoxication with methylenedioxypyrovalerone","volume":"125","author":"Ross","year":"2012","journal-title":"Am. J. Med."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0030","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/jms.1859","article-title":"Studies on the metabolism of the alpha-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC\u2013MS and LC-high-resolution MS and its detectability in urine by GC\u2013MS","volume":"45","author":"Meyer","year":"2010","journal-title":"J. Mass. Spectrom."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jms.2960","article-title":"New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC\u2013MS and LC\u2013high-resolution MS and their detectability in urine","volume":"47","author":"Meyer","year":"2012","journal-title":"J. Mass. Spectrom."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0040","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1002\/rcm.4692","article-title":"Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography\/mass spectrometry and liquid chromatography\/quadrupole time-of-flight mass spectrometry","volume":"24","author":"Strano-Rossi","year":"2010","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0045","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/FTD.0b013e3182892d11","article-title":"Monitoring haloperidol exposure in body fluids and hair of children by liquid chromatography-high-resolution mass spectrometry","volume":"35","author":"Favretto","year":"2013","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0050","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/FTD.0b013e3181c01e16","article-title":"Neonatal hair analysis by liquid chromatography-high-resolution mass spectrometry to reveal gestational exposure to venlafaxine","volume":"32","author":"Favretto","year":"2010","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/FTD.0b013e318208b693","article-title":"Urine analysis of 3,4-methylenedioxypyrovalerone in opioid-dependent patients by gas chromatography-mass spectrometry","volume":"33","author":"Ojanpera","year":"2011","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s13181-011-0196-9","article-title":"Death following recreational use of designer drug bath salts containing 3,4-Methylenedioxypyrovalerone (MDPV)","volume":"8","author":"Murray","year":"2012","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0065","first-page":"65371","article-title":"Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final order","volume":"76","author":"Drug Enforcement Administration, Department of Justice","year":"2011","journal-title":"Fed. Regist."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0070","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/j.1360-0443.2011.03399.x","article-title":"Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational \u2018ecstasy\u2019 users","volume":"106","author":"Morefield","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.forsciint.2014.08.002_bib0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0002-8223(21)39775-9","article-title":"Caffeine content of common beverages","volume":"74","author":"Bunker","year":"1979","journal-title":"J. Am. Diet Assoc."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0080","first-page":"515","article-title":"Acute psychiatric, cardiopulmonary, and neurologic effects of laboratory-confirmed use of methylenedioxypyrovalerone (MDPV) bath salts","volume":"49","author":"Spencer","year":"2011","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.forsciint.2014.08.002_bib0085","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejphar.2011.10.033","article-title":"Effects of MDMA and related analogs on plasma 5-HT: relevance to 5-HT transporters in blood and brain","volume":"674","author":"Yubero-Lahoz","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0090","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.annemergmed.2011.11.033","article-title":"Serotonin syndrome associated with MDPV use: a case report","volume":"60","author":"Mugele","year":"2012","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0095","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1124\/jpet.111.184119","article-title":"4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse","volume":"339","author":"Hadlock","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0100","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","article-title":"Pharmacological characterization of designer cathinones in vitro","volume":"168","author":"Simmler","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0105","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/npp.2011.304","article-title":"The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue","volume":"37","author":"Baumann","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.forsciint.2014.08.002_bib0110","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/npp.2012.204","article-title":"Powerful cocaine-like actions of 3,4-Methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive \u2018bath salts\u2019 products","volume":"38","author":"Baumann","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.forsciint.2014.08.002_bib0115","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1476-5381.2012.01998.x","article-title":"Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone","volume":"167","author":"Lopez-Arnau","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0120","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.euroneuro.2011.07.009","article-title":"Interaction of mephedrone with dopamine and serotonin targets in rats","volume":"22","author":"Martinez-Clemente","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0125","article-title":"Paranoid psychosis induced by consumption of methylenedioxypyrovalerone: two cases","volume":"33","author":"Antonowicz","year":"2011","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.forsciint.2014.08.002_bib0130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.forsciint.2013.04.015","article-title":"Designer cathinones \u2013 an emerging class of novel recreational drugs","volume":"231","author":"Zawilska","year":"2013","journal-title":"Forensic Sci Int."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0135","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJMc1107097","article-title":"Bath salts intoxication","volume":"365","author":"Ross","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.drugalcdep.2011.02.011","article-title":"A web-based survey on mephedrone","volume":"118","author":"Carhart-Harris","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0145","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/dta.210","article-title":"GHB and synthetic cathinones: clinical effects and potential consequences","volume":"3","author":"Karila","year":"2011","journal-title":"Drug Test Anal."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jat\/bks136","article-title":"Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results","volume":"37","author":"Marinetti","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0155","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.drugpo.2010.11.001","article-title":"Experiences with mephedrone pre- and post-legislative controls: perceptions of safety and sources of supply","volume":"22","author":"McElrath","year":"2011","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.forsciint.2014.08.002_bib0160","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.drugpo.2012.01.008","article-title":"A costly turn on: patterns of use and perceived consequences of mephedrone based head shop products amongst Irish injectors","volume":"23","author":"Van Hout","year":"2012","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.forsciint.2014.08.002_bib0165","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/j.1360-0443.2011.03502.x","article-title":"Mephedrone: use, subjective effects and health risks","volume":"106","author":"Winstock","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.forsciint.2014.08.002_bib0170","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/dta.1365","article-title":"Prevalence and co-existence of active components of \u2018legal highs\u2019","volume":"5","author":"Zuba","year":"2013","journal-title":"Drug Test Anal."},{"key":"10.1016\/j.forsciint.2014.08.002_bib0175","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1176\/ajp.142.7.859","article-title":"Three case reports of acute paroxysmal excitement associated with alprazolam treatment","volume":"142","author":"Strahan","year":"1985","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.forsciint.2014.08.002_bib0180","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0163-8343(87)90028-4","article-title":"Three case reports of behavioral disinhibition with clonazepam","volume":"9","author":"Binder","year":"1987","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.forsciint.2014.08.002_bib0185","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/106002808802200924","article-title":"Midazolam disinhibition reaction [letter]","volume":"22","author":"Miwa","year":"1988","journal-title":"Drug Intell. Clin. Pharm."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073814003168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073814003168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T22:40:02Z","timestamp":1649976002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073814003168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":37,"alternative-id":["S0379073814003168"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2014.08.002","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A mixed MDPV and benzodiazepine intoxication in a chronic drug abuser: Determination of MDPV metabolites by LC\u2013HRMS and discussion of the case","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2014.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}